4.8 Article

Structural Basis of BRCC36 Function in DNA Repair and Immune Regulation

Journal

MOLECULAR CELL
Volume 75, Issue 3, Pages 483-+

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2019.06.002

Keywords

-

Funding

  1. Novartis Presidential Fellowship
  2. Danish Cancer Society [R146-RP11394]
  3. Novartis Research Foundation
  4. NWO-VENI [863.11.007]
  5. NWO-VIDI [016.161.320]
  6. European Research Council (ERC-CoG)
  7. NIH [R01 GM124148, R01 GM127707]
  8. Lundbeck Foundation
  9. Wellcome Trust [098391/Z/12/7]
  10. Swiss National Science Foundation through Sinergia grant [CRSII3_160734/1]
  11. European Research Council under the European Union [666068]
  12. Swiss National Science Foundation (SNF) [CRSII3_160734] Funding Source: Swiss National Science Foundation (SNF)
  13. European Research Council (ERC) [666068] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

In mammals, similar to 100 deubiquitinases act on similar to 20,000 intracellular ubiquitination sites. Deubiquitinases are commonly regarded as constitutively active, with limited regulatory and targeting capacity. The BRCA1-A and BRISC complexes serve in DNA double-strand break repair and immune signaling and contain the lysine-63 linkage-specific BRCC36 subunit that is functionalized by scaffold subunits ABRAXAS and ABRO1, respectively. The molecular basis underlying BRCA1-A and BRISC function is currently unknown. Here we show that in the BRCA1-A complex structure, ABRAXAS integrates the DNA repair protein RAP80 and provides a highaffinity binding site that sequesters the tumor suppressor BRCA1 away from the break site. In the BRISC structure, ABRO1 binds SHMT2 alpha, a metabolic enzyme enabling cancer growth in hypoxic environments, which we find prevents BRCC36 from binding and cleaving ubiquitin chains. Our work explains modularity in the BRCC36 DUB family, with different adaptor subunits conferring diversified targeting and regulatory functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available